Gilman Steven C
CIK 0001379970
Director
Filings
20
Latest Jun 30, 2025
Issuers covered
4
Showing
20 of 20
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 67% | -1.8% | +2.5% | +10.1% | -27.2% |
| 90 days | 6 | 17% | -20.3% | -21.9% | +9.8% | -42.2% |
| 180 days | 6 | 50% | +4.4% | -1.3% | +33.9% | -9.6% |
| 365 days | 6 | 67% | -14.5% | +19.2% | +31.3% | -173.2% |
Issuers
Companies where Gilman Steven C has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VCEL | Vericel Corp | 9 | Oct 18, 2024 |
| AKBA | Akebia Therapeutics, Inc. | 5 | Jun 11, 2025 |
| SCYX | Scynexis Inc | 5 | Jun 30, 2025 |
| CFRX | Contrafect Corp | 1 | May 18, 2022 |
All filings
20 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|